共 5 条
[1]
DAVIES SM, IN PRESS CANCER CHEM
[2]
DEFRONZO RA, 1974, CANCER CHEMOTH REP 1, V58, P375
[3]
PINKERTON CR, 1985, CANCER CHEMOTH PHARM, V15, P258
[4]
FAILURE OF 2-MERCAPTOETHANE SULFONATE SODIUM (MESNA) TO PROTECT AGAINST IFOSFAMIDE NEPHROTOXICITY
[J].
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY,
1984, 20 (03)
:435-436
[5]
VANDYK JJ, 1972, CANCER RES, V32, P921